Equity Vaccines To Launch Malaria Vaccine Trials In Nigeria …C0NTINUE READING HERE >>>
Equity Vaccines Ltd., a pioneering subsidiary of the Equity Health Group, has set to begin clinical trials for its innovative malaria vaccine in Nigeria, marking a critical milestone in the battle against one of Africa’s most pressing public health challenges.
The company, which has been collaborating with a reputable Nigerian university, was nearing the completion of the pre-clinical stage of the vaccine’s development.
This ambitious project is part of Equity Vaccines’ plan to…
>